Old Web
English
Sign In
Acemap
>
authorDetail
>
M. L. Boytim
M. L. Boytim
Imexon
Internal medicine
Medicine
Pancreatic cancer
Gemcitabine
5
Papers
49
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer
2010
Investigational New Drugs
Stacy Moulder
N. Dhillon
Chaan S Ng
David S. Hong
Jennifer J. Wheler
Aung Naing
Susan Tse
Amy La Paglia
Robert T. Dorr
Evan M. Hersh
M. L. Boytim
Razelle Kurzrock
Show All
Source
Cite
Save
Citations (27)
A phase I study of imexon inj plus gemcitabine as first-line therapy for advanced pancreatic cancer with preclinical mechanistic study of dose limiting toxicity
2008
Journal of Clinical Oncology
Steven J. Cohen
Mark M. Zalupski
Manuel R. Modiano
Paul Conkling
Yehuda Z. Patt
Peg Davis
Robert T. Dorr
M. L. Boytim
Evan M. Hersh
Show All
Source
Cite
Save
Citations (2)
1